Renovion has raised $8.1 million in a financing round, supporting further development and planned clinical…
Vanessa Pataia
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Vanessa Pataia
Eloxx Pharmaceuticals has resumed enrollment in its Phase 2 clinical trial evaluating ELX-02 in cystic…
Pravibismane suspension, a new type of inhaled antimicrobial medication developed by M…
Different types of Staphylococcus aureus can be found persistently in the airways of…
University students with cystic fibrosis (CF) are invited to apply to…
Long-term treatment with Kalydeco (ivacaftor) in people with cystic fibrosis (CF) is associated…
Eloxx Pharmaceuticals has temporarily paused enrollment in Phase 2 clinical trials of…
The presence of heme B — a component of red blood cells — in the lungs is linked…
Poor Gut Microbiota in Infants with CF Linked to Stunted Growth in 1st Year of Life, Study Suggests
An imbalance in the microbes that populate the gut of infants with cystic fibrosis (CF) affects their growth throughout…
Arrevus announced that the U.S. Food and Drug Administration (FDA) has given a form of priority review to ARV-1801 (sodium fusidate…